Stay updated on Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's revision history.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe Taiwan site label in the Locations list was updated from Taoyuan to Taoyuan City (33305). This clarifies the geographic labeling of the site within the study's Locations section.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page’s footer revision/version label was updated from **v3.5.2** to **v3.5.3**, reflecting a site release change rather than a modification to the study record content.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 (added v3.4.3, removed v3.4.2).SummaryDifference0.0%

Stay in the know with updates to Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial page.